Skip to content
Clinical Trials – home
Jasper Therapeutics Inc.
Sponsor

Jasper Therapeutics Inc.

United States 2200 Bridge Parkway Suite 102, 94065-1186, United States

About the sponsor

Jasper Therapeutics Inc. focuses on clinical research in chronic urticaria, including chronic spontaneous urticaria, chronic inducible urticaria, and related forms such as cold urticaria and symptomatic dermographism.

  • Chronic Spontaneous Urticaria
  • Chronic Inducible Urticaria
  • Cold Urticaria
  • Symptomatic Dermographism

The sponsor’s studies address persistent wheals, itching, and antihistamine-refractory symptoms in adult populations.

About Specializations

Jasper Therapeutics Inc. runs clinical trials in conditions such as Urticaria chronic, Chronic spontaneous urticaria, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Briquilimab
  • Sponsor:Jasper Therapeutics Inc.
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Briquilimab
  • Sponsor:Jasper Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Briquilimab
  • Sponsor:Jasper Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.